Clinical Trial Update: Xingnaojing for Mild-to-severe Acute Ischemic Stroke [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Xingnaojing in mild-to-severe acute ischemic stroke (status unknown).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Xingnaojing

Snippet

Sponsor: Dongzhimen Hospital, Beijing | Conditions: Acute Ischemic Stroke, Stroke, Acute | Phase 4 | Status: UNKNOWN